A Yale School of Medicine team has created lists of criteria to help clinicians determine when next-generation sequencing ...

Conventional parameters for risk stratification prognosis for patients with low-risk myelodysplastic neoplasms, especially ...

Novel triple-drug therapies are showing promise for patients with various kinds of leukemia, researchers reported at the ...

and other myeloid neoplasms. The University of Texas MD Anderson Cancer Center and Rigel Pharmaceuticals, Inc. today announced a multi-year strategic development collaboration to expand the ...

Research showed links between smoking heavily and developing genetic mutations and a greater risk for myelodysplastic ...

A new thesis from Karolinska Institutet shows the effectiveness of flexible parametric survival models in modeling multiple ...

Dr. Cecilia Yeung’s research focuses on genomic changes, clonal evolution, and epigenetic control of gene expression in myeloid neoplasms (MDS, MPN and AML) and she has developed research expertise in ...

Incyte to Spotlight New Data, Including a Late Breaking Oral Presentation for Tafasitamab in Follicular Lymphoma, at the 2024 ...

The models were tested in the context of myeloproliferative neoplasms, a group of chronic ... transformation to acute myeloid leukemia and myelodysplastic syndromes. In her thesis, doctoral ...